The optimal time for autologous hematopoietic progenitor cell transplantation during treatment of Hodgkin's lymphoma. Foreign recommendations and russian experience

The optimal time for autologous hematopoietic progenitor cell transplantation during treatment of Hodgkin's lymphoma. Foreign recommendations and russian experience

Show other versions (1)

Autologous hematopoietic stem cell transplantation (HSCT) is the standard treatment for patients with relapsed and primary refractoryHodgkin's lymphoma (HL). According to current recommendations HSCT must be performed in first relapse or after registration of primary resistance disease. However...

Full description

Bibliographic Details
Main Authors: N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasiev, N. B. Mikhaylova, V. B. Larionova, E. A. Demina, N. G. Tyurina, M. A. Vernyuk, E. E. Karamanesht, A. G. Rumyantsev
Format: Article
Language:Russian
Published: ABV-press 2014-09-01
Series:Онкогематология
Subjects:
hodgkin's lymphoma
relapse
primary refractory disease
high-dose chemotherapy
autologous transplantation
mobilization of hematopoietic progenitor cells
survival
mortality
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/113

Internet

https://oncohematology.abvpress.ru/ongm/article/view/113

Similar Items